Related Experiment Videos
Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis
C Schmitt1, Y Perel, J L Harousseau
1Hôpital d'Enfants, Vandoeuvre les Nancy, France.
Antimicrobial Agents and Chemotherapy
|April 17, 2001
Insights
This study assessed itraconazole oral solution pharmacokinetics in neutropenic children. Effective plasma concentrations were achieved and maintained, with higher levels trending in older children.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Infectious Diseases
Background:
- Neutropenic children are at high risk for fungal infections.
- Itraconazole is a key antifungal agent.
- Understanding drug pharmacokinetics in pediatric populations is crucial for effective treatment.
Purpose of the Study:
- To evaluate the pharmacokinetics and safety of an oral itraconazole solution.
- To compare drug concentrations between different age groups of neutropenic children.
Main Methods:
- Two groups of neutropenic children were studied, stratified by age.
- Plasma concentrations of itraconazole were measured.
- Safety assessments were conducted.
Main Results:
- Oral itraconazole solution rapidly achieved effective plasma concentrations.
- These concentrations were maintained throughout the treatment period.
- A trend toward higher itraconazole plasma concentrations was observed in older children.
Conclusions:
- The oral itraconazole solution demonstrates favorable pharmacokinetics in neutropenic children.
- Age appears to influence itraconazole plasma concentrations.
- Further research may optimize dosing strategies based on age.
Abstract:
We investigated the pharmacokinetics and safety of an oral solution of itraconazole in two groups of neutropenic children stratified by age. Effective concentrations of itraconazole in plasma were reached quickly and maintained throughout treatment. The results indicate a trend toward higher concentrations of itraconazole in plasma in older children.